Page 84 - SDIR5 Abstract book 21 12 2021.
P. 84

POSTER PRESENTATIONS



               P44



                   Potential of Mesoporous Silica Nanoparticles for Applications in Targeted Treatment of
                                                           Cancer


                                                            1
                                                                                               1
                                           1
                                                                                1
                           Minja Mladenović , Mirjana Mundžić , Aleksandra Pavlović , Nikola Knežević *
                           1 BioSense Institute, University of Novi Sad, Dr Zorana Djindjica 1, 21000 Novi Sad, Serbia
                                                     *corresponding author

               Background: Mesoporous silica nanoparticles (MSN) are being vastly demonstrated in the literature as
                                                                                           2
               efficient nanocarriers for cancer therapeutics. Their high surface area (ca. 1000 m /g), well-structured
               porosity, versatile possibilities for obtaining nanocarriers of different morphologies, pore diameters and
               surface characteristics, allow construction of different nanosystems for efficient cancer targeting. Methods:
               In this study, the potential of mesoporous silica nanoparticles for applications in targeted treatment of
               cancer is presented. Results: Our team focuses on construction and surface functionalization of MSN with
               different moieties for active cancer-targeting. The drug release process can be also controlled through
               different  externally  applicable  stimuli  (eg.  light  irradiation,  magnetic  field),  or  upon  exposure  to
               intratumoral conditions such as weakly acidic environment, the elevated concentration of glutathione or
               other cancer biomarkers. In addition, MSN can be decorated with specific moieties to enable imaging of
               cancer (eg. magnetic resonance imaging (MRI)), which would enable simultaneous cancer therapy and
               diagnostics (theranostics). Conclusions: Mesoporous silica nanoparticles have substantial potentials for
               enhancing the efficacy and precision of cancer treatment.
               Keywords: mesoporous silica nanoparticles, nanocarriers, targeted anti-cancer drug delivery.



















                                                             71
   79   80   81   82   83   84   85   86   87   88   89